在 N.B.T.T. 中. 在病毒性脑膜炎的测试.

Borrelia burgdorferi antibodies in outdoor and indoor workers in south-west Sweden.

Scandinavian journal of infectious diseases·2001

Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues.

Lung cancer (Amsterdam, Netherlands)·2000

Ifosfamide in malignant mesothelioma: a phase II study.

Lung cancer (Amsterdam, Netherlands)·1999

Lack of interferon-gamma receptor does not influence the outcome of infection in murine schistosomiasis mansoni.

Scandinavian journal of immunology·1996

Lung cancer in West Sweden 1976-1985. A study of trends and survival with special reference to surgical treatment.

Acta oncologica (Stockholm, Sweden)·1996

Atypical bronchial carcinoid tumour with amyloid deposition.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·1994

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Co-formulation of IL-12 mRNA and doxorubicin in polymeric nanoparticles for simultaneous delivery in murine melanoma.

RSC pharmaceutics·2026

Dual-targeting oral nanoparticle mucosal vaccine against brucella infection: co-targeting M cells and dendritic cells.

Journal of nanobiotechnology·2026

Valsartan Repurposing to Mitigate Autoimmune Encephalomyelitis via ACE2/Ang1-7/MasR Axis Pathway Cognitive and Neuroinflammation Modulation; an Experimental and Chem-bio-informatics Study.

European journal of pharmacology·2026

Prognostic value of subretinal hyperreflective material as an imaging biomarker in the treatment of neovascular age-related macular degeneration: A systematic review.

Survey of ophthalmology·2026

Stimuli-Responsive Solid Lipid Nanoparticles for Targeted Drug Delivery in Biofilm-Resistant Infections: Advances and Challenges.

Drug development and industrial pharmacy·2026

Efficacy, safety, and tolerability of ubrogepant in the treatment of acute migraine among migraine patients in Hail City, Saudi Arabia: A retrospective case.

Journal of family medicine and primary care·2026

相关实验视频

在 N.B.T.T. 中. 在病毒性脑膜炎的测试.

相关概念视频

Borrelia burgdorferi antibodies in outdoor and indoor workers in south-west Sweden.

Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues.

Ifosfamide in malignant mesothelioma: a phase II study.

Lack of interferon-gamma receptor does not influence the outcome of infection in murine schistosomiasis mansoni.

Lung cancer in West Sweden 1976-1985. A study of trends and survival with special reference to surgical treatment.

Atypical bronchial carcinoid tumour with amyloid deposition.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Co-formulation of IL-12 mRNA and doxorubicin in polymeric nanoparticles for simultaneous delivery in murine melanoma.

Dual-targeting oral nanoparticle mucosal vaccine against brucella infection: co-targeting M cells and dendritic cells.

Valsartan Repurposing to Mitigate Autoimmune Encephalomyelitis via ACE2/Ang1-7/MasR Axis Pathway Cognitive and Neuroinflammation Modulation; an Experimental and Chem-bio-informatics Study.

Prognostic value of subretinal hyperreflective material as an imaging biomarker in the treatment of neovascular age-related macular degeneration: A systematic review.

Stimuli-Responsive Solid Lipid Nanoparticles for Targeted Drug Delivery in Biofilm-Resistant Infections: Advances and Challenges.

Efficacy, safety, and tolerability of ubrogepant in the treatment of acute migraine among migraine patients in Hail City, Saudi Arabia: A retrospective case.

相关实验视频

在 N.B.T.T. 中. 在病毒性脑膜炎的测试.

相关概念视频

相关文章